| CAT No: | CL-NFXN-02 |
| CAS No: | 124858-35-1 |
| Mol.F: | C19H21FN2O4 |
| Mol.Wt.: | 360.4 |
| Chemical Name: | 9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2 -carboxylic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to Nadifloxacin is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Nadifloxacin is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2 -carboxylic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Nadifloxacin Molecular Formula: C19H21FN2O4
Molecular Weight: 360.4
Storage: Store in a cool, dry place.
| Product Name: | Nadifloxacin |
| CAS No: | 124858-35-1 |
| Mol.F.: | C19H21FN2O4 |
| Mol.Wt.: | 360.4 |
Cat. No: CL-NFXN-NO-01
CAS No: NA
Mol. F: C5H10N2O2
Mol. Wt: 130.1
Inv. Status: In Stock
Cat. No: CL-NFXN-01
CAS No: 154357-42-3
Mol. F: C19H21FN2O4
Mol. Wt: 360.4
Inv. Status: Custom Synthesis
Cat. No: CL-NFXN-03
CAS No: 176775-77-2
Mol. F: C18H16BF2NO7
Mol. Wt: 407.1
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: